Compare BLTE & RYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLTE | RYN |
|---|---|---|
| Founded | 2018 | 1926 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.4B |
| IPO Year | 2021 | 1994 |
| Metric | BLTE | RYN |
|---|---|---|
| Price | $161.06 | $21.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $198.00 | $26.00 |
| AVG Volume (30 Days) | 153.2K | ★ 2.8M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 11.73% |
| EPS Growth | N/A | ★ 26.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $484,485,000.00 |
| Revenue This Year | N/A | $214.97 |
| Revenue Next Year | $492.11 | $10.35 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $62.18 | $19.49 |
| 52 Week High | $200.00 | $27.10 |
| Indicator | BLTE | RYN |
|---|---|---|
| Relative Strength Index (RSI) | 51.24 | 45.05 |
| Support Level | $158.32 | $20.97 |
| Resistance Level | $172.02 | $21.90 |
| Average True Range (ATR) | 6.82 | 0.51 |
| MACD | -0.74 | -0.07 |
| Stochastic Oscillator | 27.85 | 20.80 |
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.
Rayonier Inc is a timberland real estate investment trust engaged in the ownership, management, and investment of timberlands. The company operates through Southern Timber, Pacific Northwest Timber, and Real Estate segments. The Southern Timber and Pacific Northwest Timber segments are involved in harvesting timber and related activities, as well as value-added services such as licensing properties for hunting, leasing land for mineral extraction and communication infrastructure, land-based solutions including carbon capture and solar energy, and log trading. The Real Estate segment is engaged in land sales across various categories, as well as residential and commercial leasing activities. It generates the majority of its revenue from the Southern Timber segment.